China IVD Market Opportunities


China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024. Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market.

Read »
Created by renubresearch 2 years 37 weeks ago – Made popular 2 years 37 weeks ago
Category: Health   Tags:

User login

EzySpot is a news/social bookmarking site.